Calyxt identifies more than 15,000 unique chemical signatures in lab-scale biofactory™ production run

Roseville, minn., dec. 8, 2021 /prnewswire/ -- calyxt, inc.  (nasdaq: clxt), a plant-based synthetic biotechnology company, today announced the completion of a key milestone in its lab-scale biofactory™ manufacturing system.
CLXT Ratings Summary
CLXT Quant Ranking